相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies
Lanying Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
A recombinant mimetics of the HIV-1 gp41 prehairpin fusion intermediate fused with human IgG Fc fragment elicits neutralizing antibody response in the vaccinated mice
Zhi Qi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Novel Recombinant Engineered gp41 N-terminal Heptad Repeat Trimers and Their Potential as Anti-HIV-1 Therapeutics or Microbicides
Xi Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Contributions of the Avian Influenza Virus HA, NA, and M2 Surface Proteins to the Induction of Neutralizing Antibodies and Protective Immunity
Baibaswata Nayak et al.
JOURNAL OF VIROLOGY (2010)
A Single Immunization with CoVaccine HT-Adjuvanted H5N1 Influenza Virus Vaccine Induces Protective Cellular and Humoral Immune Responses in Ferrets
R. Bodewes et al.
JOURNAL OF VIROLOGY (2010)
Gastrointestinal Delivery of Baculovirus Displaying Influenza Virus Hemagglutinin Protects Mice against Heterologous H5N1 Infection
Mookkan Prabakaran et al.
JOURNAL OF VIROLOGY (2010)
Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study
Isabel Leroux-Roels et al.
VACCINE (2010)
Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin
Larry R. Smith et al.
VACCINE (2010)
Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors
John C. Martyn et al.
ARCHIVES OF VIROLOGY (2009)
Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells
Lanying Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
DNA Vaccination with a Single-Plasmid Construct Coding for Viruslike Particles Protects Mice against Infection with a Highly Pathogenic Avian Influenza A Virus
Judit Szecsi et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 Highly Pathogenic Avian Influenza
John Steel et al.
JOURNAL OF VIROLOGY (2009)
Antibodies against H5 and H9 Avian Influenza among Poultry Workers in China
Ming Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Heterosubtype Neutralizing Responses to Influenza A (H5N1) Viruses Are Mediated by Antibodies to Virus Haemagglutinin
Jean-Michel Garcia et al.
PLOS ONE (2009)
The First Pandemic of the 21st Century: A Review of the 2009 Pandemic Variant Influenza A (H1N1) Virus
Nikole M. Scalera et al.
POSTGRADUATE MEDICINE (2009)
Preparation and immune activity analysis of H5N1 subtype avian influenza virus recombinant protein-based vaccine
Q. M. Xie et al.
POULTRY SCIENCE (2009)
SWINE FLU After Delays, WHO Agrees: The 2009 Pandemic Has Begun
Jon Cohen et al.
SCIENCE (2009)
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus
Zuzana Biesova et al.
VACCINE (2009)
Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses
J. H. C. M. Kreijtz et al.
VACCINE (2009)
Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses
Graeme E. Price et al.
VACCINE (2009)
Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses
Ami Patel et al.
VACCINE (2009)
Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
Tino F. Schwarz et al.
VACCINE (2009)
Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza
Yoko Shoji et al.
VACCINE (2009)
Virus-Like Particle Vaccine Comprised of the HA, NA, and M1 Proteins of an Avian Isolated H5N1 Influenza Virus Induces Protective Immunity Against Homologous and Heterologous Strains in Mice
Pan Tao et al.
VIRAL IMMUNOLOGY (2009)
Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
Lanying Du et al.
VIROLOGY (2009)
Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets
Surender Khurana et al.
PLOS MEDICINE (2009)
Improvement of thermostability of recombinant collagen-like protein by incorporating a foldon sequence
Chunling Du et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2008)
Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection
Lanying Du et al.
JOURNAL OF IMMUNOLOGY (2008)
Generation and characterization of an H5N1 avian influenza virus hemagglutinin glycoprotein pseudotyped lentivirus
Songlin Zhang et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus
Chih-Jen Wei et al.
JOURNAL OF VIROLOGY (2008)
Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus
Bo-Jian Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses
David H. Holman et al.
VACCINE (2008)
Immunogenicity of the outer domain of a HIV-1 clade C gp120
Hongying Chen et al.
RETROVIROLOGY (2007)
Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
Lanying Du et al.
VACCINE (2007)
Food markets with live birds as source of avian influenza
Ming Wang et al.
EMERGING INFECTIOUS DISEASES (2006)
Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial
Jiangtao Lin et al.
LANCET (2006)
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:: phase I randomised trial
Jean-Louis Bresson et al.
LANCET (2006)
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
JJ Treanor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies
YX He et al.
JOURNAL OF IMMUNOLOGY (2005)
Probable person-to-person transmission of avian influenza A (H5N1)
K Ungchusak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
YX He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Assembly of stable human type I and III collagen molecules from hydroxylated recombinant chains in the yeast Pichia pastoris -: Effect of an engineered C-terminal oligomerization domain foldon
O Pakkanen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections
VC Huber et al.
JOURNAL OF IMMUNOLOGY (2001)